Keyphrases
Metastatic Breast Cancer
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Potential Therapeutic Strategies
100%
Breast Cancer Growth
100%
Urokinase
100%
Breast Cancer Invasion
100%
Tumor Metastasis
23%
Overexpressing
15%
Liver
15%
Overexpression
15%
Lymph Node
15%
Breast Cancer Cell Lines
15%
Invasive Ability
15%
Experimental Animals
15%
Large Tumors
15%
Tumor Cells
7%
Gene Transcription
7%
Tumor Invasion
7%
Breast Cancer
7%
Tumor
7%
Tumor Progression
7%
Lung
7%
Malignancy
7%
Breast Cancer Patients
7%
Cell Growth
7%
Spleen
7%
Combination Therapy
7%
Serine Protease
7%
Proliferative Activity
7%
Primary Tumor
7%
Cell Surface Receptor
7%
Inoculation
7%
Highly Aggressive
7%
Control Cell
7%
Malignant Cells
7%
Mammary Fat Pad
7%
Large Volume
7%
Fisher
7%
Cell Invasion
7%
Syngeneic
7%
Antiestrogen
7%
Hormone Therapy
7%
Cell Metastasis
7%
Advanced Breast Cancer
7%
Syngeneic Model
7%
Synthetic Inhibitors
7%
Benzo
7%
Matrix Degradation
7%
Thiophene
7%
F344 Rats
7%
Non-steroidal
7%
Experimental Cells
7%
Antiproteolytic
7%
Primary Tumor Volume
7%
Gene Transfer Techniques
7%
Pharmacology, Toxicology and Pharmaceutical Science
Tamoxifen
100%
Receptor
100%
Breast Cancer
100%
Tumor Invasion
100%
Cancer Growth
100%
Metastasis Potential
100%
Urokinase
100%
Neoplasm
50%
Experimental Animal
33%
Primary Tumor
33%
Fischer 344 Rat
16%
Endocrine Therapy
16%
Tumor Growth
16%
Proteinase Inhibitor
16%
Cell Surface Receptor
16%
Antiestrogen
16%
Serine Proteinase
16%
Benzothiophene
16%
Gene Delivery
16%
Combination Therapy
16%
Urokinase Receptor
16%
Immunology and Microbiology
Experimental Animal
100%
Syngenic
100%
Breast Cancer Cell Line
100%
Lymph Node
100%
Urokinase Receptor
50%
Genetic Transcription
50%
Tumor Cell
50%
Cell Surface
50%
Tumor Volume
50%
Gene Transfer
50%
Fischer 344 Rat
50%
Fat Pad
50%
Wild Type
50%
Cell Growth
50%
Serine
50%